David J. Mazzo - 10 Jan 2022 Form 4 Insider Report for CALADRIUS BIOSCIENCES, INC. (LSTA)

Role: Chief Executive Officer, Director
Signature: David J. Mazzo, by: /s/ Todd C. Girolamo, Esq., Attorney-in-Fact
Issuer symbol: LSTA
Transactions as of: 10 Jan 2022
Net transactions value: -$66,210
Form type: 4
Filing time: 12 Jan 2022, 15:21:57 UTC
Next filing: 18 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LSTA	Common Stock	Award	$0	+401,000	+127%	$0.000000	717,297	10 Jan 2022	Direct	F1, F2
transaction	LSTA	Common Stock	Tax liability	$51,728	-56,410	-7.9%	$0.9170	660,887	10 Jan 2022	Direct	F2, F3
transaction	LSTA	Common Stock	Tax liability	$14,482	-16,740	-2.5%	$0.8651	644,147	11 Jan 2022	Direct	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LSTA	Stock Option (Right to Buy)	Award	$0	+200,000		$0.000000	200,000	10 Jan 2022	Common Stock	200,000	$0.9170	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 401,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
F2	Includes 424,750 unvested restricted stock.
F3	Shares withheld as payment of a tax liability on vesting of restricted stock.
F4	Includes 395,000 unvested restricted stock.
F5	One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.